| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.5 | 0.007 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |